NEW YORK (GenomeWeb News) — Sigma-Aldrich has paid Sangamo BioSciences a $1 million milestone as part of a deal for Sangamo to develop zinc finger nuclease reagents for the research market, Sangamo said this week.

The payment was a production milestone under an agreement the companies made in July 2007.

ZFNs can be designed to target any gene in any organism, Sangamo said, and can be used to rapidly make precise changes to a cell's characteristics

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.